Oxeladin citrate
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162642This classification denotes an antitussive agent with the molecular formula C20H33NO3.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5AEV5C340C, chemically known as benzeneacetic acid, .alpha.,.alpha.-diethyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), but more generally known as oxeladin citrate, which bears US NIH Compound Identifier 40384. European Medicines Agency schedules oxeladin citrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09513MIG. Most nations, for tariff purposes, schedule oxeladin citrate under HS 29221980. SMILES: CCC(CC)(C1CCCCC1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.